Symposium on

1
Symposium on Biomarkers in Drug Development From
Discovery to Validation 9th October 2006 at the
UCD Conway Institute
Focus of the symposium will be on identification
and validation of biomarkers of efficacy and
safety. Coffee/tea (10.30am-11.00am) Biomarker
Discovery Session (11.00am-1.00pm) Transcriptomic
Approaches Used in Safety Assessment Philip
Hewitt, Merck, Germany Recent Applications of
Protein Arrays to Biomarker Discovery Dolores
Cahill, UCD Conway Institute, Ireland Glycomics
and Biomarker Discovery Pauline Rudd, UCD Conway
Institute, Ireland Proteomics Expression
Analysis Stephen Pennington, UCD Conway
Institute, Ireland Lunch (1.00pm-2.00pm) Biomark
er Validation Session (2.00pm-3.30pm) From
Proteomic Profiling to Multiplex Assay
Development Huw Davies, Ciphergen
Biosystems Tissue Microarrays Applications in
Biomarker Validation Donal Brennan, UCD Conway
Institute, Ireland Route to Biomarker Validation
with the FDA Michael Kammueller, Novartis Pharma,
Switzerland Coffee/tea (3.30pm-4.00pm) Viewpoint
Session (4.00-5.00pm) Biomarkers in Safety
Assessment The PredTox Consortium David Tweats,
The Medical School, University of Wales, Swansea,
UK Case for a Centre for Biomarker Research in
Ireland Barry Heavey, IDA, Ireland Registration
fee is 25 euro. Please e-mail karen.power_at_ucd.ie
for details.